Biomarkers and surrogate endpoints
- PMID: 15842546
- PMCID: PMC1884846
- DOI: 10.1111/j.1365-2125.2005.02435.x
Biomarkers and surrogate endpoints
References
-
- Brotman B, Prince AM. Gamma-glutamyltransferase as a potential surrogate marker for detection of the non-A, non-B carrier state. Vox Sang. 1988;54:144–7. - PubMed
-
- Paone JF, Waalkes TP, Baker RR, Shaper JH. Serum UDP-galactosyl transferase as a potential biomarker for breast carcinoma. J Surg Oncol. 1980;15:59–66. - PubMed
-
- Boone CW, Kelloff GJ. Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention. J Cell Biochem Suppl. 1993;17F:37–48. - PubMed
-
- NIH Definitions Working Group. Biomarkers and Surrogate Endpoints. Amsterdam: Elsevier; 2000. Biomarkers and surrogate endpoints in clinical research: definitions and conceptual model; pp. 1–9.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources